Stock listing

NBIX Stock Price, News, Filings & Events — Neurocrine Biosciences, Inc.

Selected listing: NBIX · NASDAQ · USD · US

NBIX:NASDAQ is the primary listing for Neurocrine Biosciences, Inc., a biopharmaceutical company based in the United States. Neurocrine is dedicated to developing innovative treatments for neurological and endocrine disorders, aiming to enhance patient outcomes. With a market capitalization of around $17.67 billion, the company is actively involved in advancing its therapeutic pipeline and regularly updates investors through news, filings, and events related to its progress in the biopharmaceutical sector.

NBIX:NASDAQUSDUSUpdated July 24, 2026
Neurocrine Biosciences, Inc. logo
Ticker
NBIX:NASDAQ
Asset type
Stock
Market cap
$17.67B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Neurocrine Biosciences, Inc. NBIX:NASDAQ stock context

NBIX:NASDAQ is the primary listing for Neurocrine Biosciences, Inc., a biopharmaceutical company based in the United States. Neurocrine is dedicated to developing innovative treatments for neurological and endocrine disorders, aiming to enhance patient outcomes. With a market capitalization of around $17.67 billion, the company is actively involved in advancing its therapeutic pipeline and regularly updates investors through news, filings, and events related to its progress in the biopharmaceutical sector.

Research Neurocrine Biosciences, Inc.

Alternate listings